In 2010 SiBS completed commissioning works on a new 5,600m2 expansion to the existing manufacturing facility.
Established in 2001, Genzyme Ireland is situated on a 37 acre site in Waterford. This multi phased Biopharmaceutical facility has a capital investment of over €400 million and employs over 450 personnel. It is state-of-the-art facility for finishing of biopharmaceuticals and employs a high level of automation, including Manufacturing Execution Systems. The first phase of development, a tableting suite with packaging lines, for manufacture of Renagel has been supplying product to Dialysis patients globally since 2003. The Biologics Fill Finish facility commenced commercial supply of thymoglobulin in 2006 to global markets. The third manufacturing plant commenced operations in 2009.